Novartis AG — Director's Dealing 2014

Aug 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDENIX PHARMACEUTICALS INC (IDIX)
CIK: 0001093649
Period of Report: 2014-08-05

Reporting Person: NOVARTIS PHARMA AG (10% Owner)
Reporting Person: NOVARTIS AG (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-05	Common Stock	U	33320674	$24.50	Disposed	0	Direct